Fund Holdings — Ally Bridge Group (NY) LLC

Total Portfolio Value
$179.89M
Total Bought
$119.81M
Total Sold
$123.13M
Net Transaction
-$3.32M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
BLUEPRINT MEDICINES CORP0160,950+160,950015,2688.49%+15,268
CG ONCOLOGY INC(CGON)0320,378+320,378014,0657.82%+14,065
VERONA PHARMA PLC0736,738+736,738011,8546.59%+11,854
MIND MEDICINE MINDMED INC01,001,452+1,001,45209,4145.23%+9,414
JASPER THERAPEUTICS INC(JSPR)0289,943+289,94308,5134.73%+8,513
PRAXIS PRECISION MEDICINES I(PRAX)70,424159,486+89,0621,5699,7325.41%+8,163
KURA ONCOLOGY INC(KURA)0365,044+365,04407,7864.33%+7,786
INSMED INC(INSM)0250,000+250,00006,7833.77%+6,783
DIANTHUS THERAPEUTICS INC(DNTH)0216,968+216,96806,5093.62%+6,509
LYRA THERAPEUTICS INC01,003,741+1,003,74106,2433.47%+6,243
LONGBOARD PHARMACEUTICALS IN0270,559+270,55905,8443.25%+5,844
AVADEL PHARMACEUTICALS PLC347,036547,036+200,0004,9009,2395.14%+4,339
MERUS N V274,923255,928-18,9957,56011,5246.41%+3,964
RAPT THERAPEUTICS INC0420,000+420,00003,7722.10%+3,772
MERSANA THERAPEUTICS INC0801,437+801,43703,5902.00%+3,590
MARINUS PHARMACEUTICALS INC0394,773+394,77303,5691.98%+3,569
GERON CORP(GERN)2,971,6392,760,497-211,1426,2709,1105.06%+2,839
XENON PHARMACEUTICALS INC(XENE)241,961309,369+67,40811,14513,3187.40%+2,174
SOLENO THERAPEUTICS INC309,950336,486+26,53612,47514,4028.01%+1,926
PROMIS NEUROSCIENCES INC1,066,6741,059,582-7,0921,2272,0241.13%+797
CONTEXT THERAPEUTICS INC(CNTX)725,951725,95108201,0020.56%+181
MEDAVAIL HOLDINGS INC117,8970-117,8975290—-529
COMPASS THERAPEUTICS INC(CMPX)834,6300-834,6301,3020—-1,302
OLEMA PHARMACEUTICALS INC(OLMA)659,035559,035-100,0009,2466,3283.52%-2,918
AMYLYX PHARMACEUTICALS INC(AMLX)275,7730-275,7734,0590—-4,059
HARPOON THERAPEUTICS INC428,4000-428,4004,8710—-4,871
AMBRX BIOPHARMA INC385,3830-385,3835,4880—-5,488
ALPINE IMMUNE SCIENCES INC357,2710-357,2716,8100—-6,810
AXSOME THERAPEUTICS INC(AXSM)100,8620-100,8628,0280—-8,028
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)143,4790-143,4798,6650—-8,665
APELLIS PHARMACEUTICALS INC
COM
150,0000-150,0008,9790—-8,979
INTRA-CELLULAR THERAPIES INC141,3480-141,34810,1230—-10,123
CYMABAY THERAPEUTICS INC489,9380-489,93811,5720—-11,572
ARGENX SE - ADR(ARGX)35,0000-35,00013,3150—-13,315
JASPER THERAPEUTICS INC(JSPR)3,659,2550-3,659,25528,8720—-28,872
Page 1 of 1
Ally Bridge Group (NY) LLC — 13F Holdings — Q1 2024 | TickerTrail